Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,97 EUR | 0,00% | +28,39% | +39,49% |
Omzet 2023 | 2,23 mln. 2,39 mln. | Omzet 2024 * | 37,83 mln. 40,53 mln. | Marktkapitalisatie | 129 mln. 138 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -23 mln. -24,64 mln. | Nettowinst (verlies) 2024 * | -5 mln. -5,36 mln. | EV/omzet 2023 | 36,2 x |
Nettoschuld 2023 * | 33,7 mln. 36,11 mln. | Nettoschuld 2024 * | 46,6 mln. 49,92 mln. | EV/omzet 2024 * | 4,64 x |
K/w-verhouding 2023 |
-3,63
x | K/w-verhouding 2024 * |
-13,9
x | Werknemers | 62 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 72,4% |
Recentste transcriptie over OSE Immunotherapeutics
1 week | +28,39% | ||
Lopende maand | +22,84% | ||
1 maand | +24,38% | ||
3 maanden | +56,69% | ||
6 maanden | +43,17% | ||
Lopend jaar | +39,49% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Nicolas Poirier
CEO | Chief Executive Officer | 42 | 31-05-16 |
Director of Finance/CFO | - | 01-05-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 69 | 17-11-04 | |
Director/Board Member | 66 | 22-06-23 | |
Director/Board Member | 66 | 18-02-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 5,97 | 0,00% | 376 959 |
22-04-24 | 5,97 | +10,97% | 410 921 |
19-04-24 | 5,38 | +7,60% | 328 456 |
18-04-24 | 5 | +2,56% | 128 837 |
17-04-24 | 4,875 | +4,84% | 248 766 |
Real Time Euronext Paris, 23 april 2024 om 17:35 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+39,49% | 137 mln. | |
+3,13% | 42,11 mld. | |
+48,83% | 40,08 mld. | |
+8,49% | 40 mld. | |
-10,82% | 26,87 mld. | |
+8,26% | 24,58 mld. | |
-23,69% | 18,44 mld. | |
+1,58% | 11,94 mld. | |
+32,83% | 11,66 mld. | |
+6,63% | 11,01 mld. |